Options Trading News

April 11, 2014  Fri 11:13 AM CT

A large trader is looking for a sharp move in Horizon Pharma.

optionMONSTER systems show that 5,000 May 13 calls were purchased for $1.55, above the listed ask price at the time on an already-wide bid/ask spread. This is clearly a new position, as the previous open interest at that strike was just 167 contracts.

Less than 2 minutes after the calls were bought, the session's biggest block of HZNP stock traded as 250,000 shares were sold for $12.60. That exactly matches the delta of the calls, so this is a directionally neutral play that is looking for a sharp move in either direction and/or for volatility to be higher than that implied by the options' price. (See our Education section)

HZNP is off fractionally at $13.02 in midday trading. The arthritis-drug developer briefly traded above $18 three weeks ago at a record high. The stock has been trending higher since August, when it was as low as $2.11.
Share this article with your friends

Related Stories


How the bulls are playing Horizon

September 24, 2015

The drug company has gotten slammed along with other biotech names recently, but traders apparently believe that the selling is overdone.


Bulls returning to Horizon Pharma

September 18, 2015

The pharmaceutical company has grown by acquisition and is currently attempting a hostile takeover of pain-drug maker DepoMed.



The fastest money in the market
View full report »

Premium Services

Archived Webinar

Education & Strategy

Options Academy: More on the Covered Call Strategy

Last week, we talked about the Covered Call and the misconceptions that surround it. We spoke about how an investor must realize that the Covered Call is actually a premium collection strategy and not so much a directional one. If an investor can grasp this idea, the investor stands to do a heck of a lot better in the strategy than they currently do.

View more education articles »